Clinical Trials in Atlanta

Showing 5681-5700 of 19,805 trials

BATwire Implant Kit

NCT04600791

The purpose of this clinical investigation is to develop valid scientific evidence for the safety and effectiveness of the Barostim System delivered by the BATwire Implant Kit (BATwire Kit) in subjects with heart failure. Subjects may be enrolled if they meet the FDA approved PMA indication for use for the Barostim NEO or Barostim NEO2 device: Subjects who remain symptomatic despite treatment with guideline-directed medical therapy, are NYHA Class III or Class II (who had a recent history of Class III), have a left ventricular ejection fraction ≤ 35%, a NT-proBNP \< 1600 pg/ml and excludes patients indicated for Cardiac Resynchronization Therapy (CRT) according to AHA/ACC/ESC guidelines.

Heart Failure

CVRx, Inc.93 participantsStarted Jan 2021

Mesa, Arizona, United States • Scottsdale, Arizona, United States • Orlando, Florida, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

NCT00667823

The main objective of the AC 055 303/SERAPHIN OL study, which will follow the AC 055 302/SERAPHIN study, will be to assess the long-term safety and tolerability of ACT 064992 in patients with symptomatic PAH.

Pulmonary Arterial Hypertension

Actelion550 participantsStarted Oct 2008

Birmingham, Alabama, United States • Phoenix, Arizona, United States • La Jolla, California, United States +155 more locations

BATwire Implant Kit

Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

Find Trials by Condition in Atlanta

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Electrical Muscle Stimulation with 1064 Nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

A Study of Guselkumab in Participants With Active Lupus Nephritis

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris

Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

In-Utero Endoscopic Correction of Spina Bifida

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Study to Estimate How Common it is to Have Genetic Variants Associated With NAFLD

Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension